Diabetic nephropathy in the elderly

Area of Science:

• Nephrology
• Endocrinology
• Geriatrics

Background:

• Diabetes mellitus is a significant risk factor for macro- and microvascular complications, including cardiovascular and cerebrovascular diseases, blindness, and limb amputations.
• Diabetic nephropathy is the primary driver of end-stage renal disease (ESRD), posing substantial challenges to healthcare budgets and dialysis/transplantation facilities.
• The increasing prevalence of elderly patients with diabetes-induced uremia is dominating nephrology practice, necessitating integrated geriatric and endocrine care.

Purpose of the Study:

• To highlight the growing burden of diabetic nephropathy as a cause of ESRD.
• To discuss the challenges faced by nephrology in managing elderly diabetic patients with uremia.
• To underscore the positive impact of emerging renoprotective regimens on slowing ESRD progression.

Main Methods:

• Review of current literature on diabetic nephropathy and ESRD.
• Analysis of the impact of diabetes on renal function and associated complications.
• Evaluation of the effectiveness of renoprotective strategies in diabetes management.

Main Results:

• Diabetic nephropathy is a major cause of ESRD, leading to increased demand for renal replacement therapies.
• Elderly diabetic patients with uremia present complex management challenges requiring multidisciplinary approaches.
• Emerging renoprotective treatments have demonstrated efficacy in reducing the incidence of ESRD in diabetic individuals.

Conclusions:

• Diabetic nephropathy represents a critical public health issue due to its high association with ESRD.
• Effective management of diabetes and its renal complications is crucial for reducing the burden of ESRD.
• There is a strong basis for optimism that advancements in renoprotective therapies will make diabetic kidney failure a preventable condition within the next decade.